Converging quality by design, artificial intelligence, and biofoundry automation: A new paradigm for scalable circular biomanufacturing.

Convergence of Quality by Design, AI-assisted biological design, and automated biofoundry workflows is shaping a more replicable pathway from lab innovation to industrial circular biomanufacturing.

• Why it matters: The field needs a scalable, predictable route from synthetic biology concepts to industrial deployment, but current development remains fragmented across design, testing, and quality/regulatory constraints.
• What they did: The review synthesizes how the Design-Build-Test-Learn cycle is shifting from a research heuristic to a systematic industrial framework, and how toolsets transfer across microbial, plant, and animal systems.
• The result: It argues that this convergence enables benchmarking against conventional alternatives and helps address scale-up, regulatory, and societal bottlenecks via market-scale case studies, while contrasting EU vs US policy divergence.

AI summary of the abstract · may contain errors · not medical advice · read the paper.